Certain delivery systems that are used to insert a pulmonary valve have an increased risk of distal tip detachment, the company said. The valve itself is not affected by the recall.

OU Health performed a rare dual pulmonary valve procedure using Medtronic Harmony valves, one of only two known cases ...

Physicians at OU Health have successfully performed a rare and technically complex heart procedure that placed two artificial ...

Memorial Regional Hospital and Joe DiMaggio Children's Hospital are advancing congenital heart care by completing their first implantation of the innovative VenusP-Valve System, a minimally invasive ...

Clinical trials have started for the first prosthetic pulmonary valve replacement that is specifically designed for pediatric patients and can expand over time inside a child's anatomy. Instead of ...

EINDHOVEN, the Netherlands & ZURICH--(BUSINESS WIRE)--Xeltis, a clinical-stage company with the most advanced polymer-based restorative cardiovascular devices, today announced that it has started the ...

Jasmine Harvey, 21, was born with the complex congenital heart condition tetralogy of Fallot and underwent open-heart surgery at St. Joseph’s Children’s Hospital when she was just 4-months-old. This ...

Heart valves can be replaced with open heart surgery or with less invasive procedures that don’t require your chest to be opened. Known as transcatheter valve replacement, this type of procedure has ...

Researchers from the BioTis laboratory (Inserm/University of Bordeaux, Bordeaux, France) have developed a pulmonary valve using human collagen. Such a device could revolutionize the treatment of ...

The FDA gave the greenlight to transcatheter pulmonic valve replacement with the Sapien 3 system plus an adaptive pre-stent landing zone, dubbed Alterra, for patients with congenital heart disease.

Absent pulmonary valve syndrome is a rare congenital cardiac anomaly characterised by failure of pulmonary valve development, resulting in severe regurgitation and aneurysmal dilatation of the ...

PolyVascular, a medtech company developing a non-surgical heart valve for children with congenital heart disease, has obtained $2 million in funding from non-profit pediatric initiative, CobiCure ...